DK1701942T3 - Inhibitorer for ikke-nukleotid revers transkriptase - Google Patents
Inhibitorer for ikke-nukleotid revers transkriptaseInfo
- Publication number
- DK1701942T3 DK1701942T3 DK04809207.6T DK04809207T DK1701942T3 DK 1701942 T3 DK1701942 T3 DK 1701942T3 DK 04809207 T DK04809207 T DK 04809207T DK 1701942 T3 DK1701942 T3 DK 1701942T3
- Authority
- DK
- Denmark
- Prior art keywords
- alkyl
- orx
- nrxrx
- reverse transcriptase
- transcriptase inhibitors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- AIDS & HIV (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0400021A SE0400021D0 (sv) | 2004-01-08 | 2004-01-08 | Non-nucleoside reverse transcriptase inhibitors |
| SE0400585A SE0400585D0 (sv) | 2004-03-09 | 2004-03-09 | NNRTI Antivirals |
| PCT/SE2004/002034 WO2005066131A1 (en) | 2004-01-08 | 2004-12-30 | Non-nucleotide reverse transcriptase inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1701942T3 true DK1701942T3 (da) | 2010-04-06 |
Family
ID=34752289
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK04809207.6T DK1701942T3 (da) | 2004-01-08 | 2004-12-30 | Inhibitorer for ikke-nukleotid revers transkriptase |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US7915295B2 (https=) |
| EP (1) | EP1701942B1 (https=) |
| JP (1) | JP4762917B2 (https=) |
| AT (1) | ATE451357T1 (https=) |
| AU (1) | AU2004312284B2 (https=) |
| BR (1) | BRPI0418306B8 (https=) |
| CA (1) | CA2550187C (https=) |
| DE (1) | DE602004024584D1 (https=) |
| DK (1) | DK1701942T3 (https=) |
| EA (1) | EA009700B1 (https=) |
| ES (1) | ES2337794T3 (https=) |
| IL (1) | IL176740A (https=) |
| NZ (1) | NZ548367A (https=) |
| SG (1) | SG149070A1 (https=) |
| WO (1) | WO2005066131A1 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1534276B1 (en) * | 2002-09-05 | 2008-11-05 | Medivir AB | Non-nucleoside reverse transcriptase inhibitors |
| US7388008B2 (en) | 2004-08-02 | 2008-06-17 | Ambrilia Biopharma Inc. | Lysine based compounds |
| ES2539527T3 (es) * | 2005-04-27 | 2015-07-01 | Taimed Biologics, Inc. | Método para mejorar la farmacocinética de los inhibidores de las proteasas y de los precursores de los inhibidores de las proteasas |
| CN101405293B (zh) | 2005-11-30 | 2013-03-13 | 中裕新药股份有限公司 | 天冬氨酰基蛋白酶抑制剂基于赖氨酸的前体药物及其制备方法 |
| GB0608876D0 (en) | 2006-05-05 | 2006-06-14 | Medivir Ab | Combination therapy |
| ATE552245T1 (de) | 2006-05-15 | 2012-04-15 | Merck Sharp & Dohme | Antidiabetische bicyclische verbindungen |
| US8410300B2 (en) | 2006-09-21 | 2013-04-02 | Taimed Biologics, Inc. | Protease inhibitors |
| WO2016123387A1 (en) * | 2015-01-30 | 2016-08-04 | Genentech, Inc. | Therapeutic compounds and uses thereof |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR9906933A (pt) * | 1998-01-16 | 2001-11-27 | Medivir Ab | Antiviróticos |
| WO1999051613A1 (en) * | 1998-04-03 | 1999-10-14 | Medivir Ab | Prodrugs of phosphorous-containing pharmaceuticals |
| SE0100733D0 (sv) * | 2001-03-05 | 2001-03-05 | Medivir Ab | Non-nucleoside reverse transcriptase inhibitors |
| SE0102867D0 (sv) * | 2001-08-28 | 2001-08-28 | Medivir Ab | Non-nucleoside reverse transcriptase inhibitors |
| EP1534276B1 (en) * | 2002-09-05 | 2008-11-05 | Medivir AB | Non-nucleoside reverse transcriptase inhibitors |
-
2004
- 2004-12-30 JP JP2006549182A patent/JP4762917B2/ja not_active Expired - Fee Related
- 2004-12-30 DK DK04809207.6T patent/DK1701942T3/da active
- 2004-12-30 CA CA2550187A patent/CA2550187C/en not_active Expired - Fee Related
- 2004-12-30 EA EA200601289A patent/EA009700B1/ru not_active IP Right Cessation
- 2004-12-30 US US10/584,933 patent/US7915295B2/en not_active Expired - Fee Related
- 2004-12-30 EP EP04809207A patent/EP1701942B1/en not_active Expired - Lifetime
- 2004-12-30 ES ES04809207T patent/ES2337794T3/es not_active Expired - Lifetime
- 2004-12-30 BR BRPI0418306A patent/BRPI0418306B8/pt not_active IP Right Cessation
- 2004-12-30 AT AT04809207T patent/ATE451357T1/de not_active IP Right Cessation
- 2004-12-30 SG SG200809639-8A patent/SG149070A1/en unknown
- 2004-12-30 DE DE602004024584T patent/DE602004024584D1/de not_active Expired - Lifetime
- 2004-12-30 WO PCT/SE2004/002034 patent/WO2005066131A1/en not_active Ceased
- 2004-12-30 AU AU2004312284A patent/AU2004312284B2/en not_active Ceased
- 2004-12-30 NZ NZ548367A patent/NZ548367A/en not_active IP Right Cessation
-
2006
- 2006-07-06 IL IL176740A patent/IL176740A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EA009700B1 (ru) | 2008-02-28 |
| EP1701942A1 (en) | 2006-09-20 |
| BRPI0418306A (pt) | 2007-05-02 |
| JP2007519640A (ja) | 2007-07-19 |
| AU2004312284B2 (en) | 2010-08-05 |
| AU2004312284A1 (en) | 2005-07-21 |
| CA2550187C (en) | 2012-08-07 |
| JP4762917B2 (ja) | 2011-08-31 |
| IL176740A (en) | 2011-09-27 |
| AU2004312284A2 (en) | 2005-07-21 |
| WO2005066131A1 (en) | 2005-07-21 |
| BRPI0418306B1 (pt) | 2018-09-18 |
| ATE451357T1 (de) | 2009-12-15 |
| DE602004024584D1 (de) | 2010-01-21 |
| HK1101400A1 (en) | 2007-10-18 |
| EA200601289A1 (ru) | 2006-12-29 |
| US7915295B2 (en) | 2011-03-29 |
| NZ548367A (en) | 2010-06-25 |
| ES2337794T3 (es) | 2010-04-29 |
| CA2550187A1 (en) | 2005-07-21 |
| SG149070A1 (en) | 2009-01-29 |
| BRPI0418306B8 (pt) | 2021-05-25 |
| US20080070951A1 (en) | 2008-03-20 |
| IL176740A0 (en) | 2006-10-31 |
| EP1701942B1 (en) | 2009-12-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA200602060A1 (ru) | Производные пирролидин-2-она и пиперидин-2-она, используемые в качестве ингибиторов 11-бета-гидроксистероид-дегидрогеназы | |
| JP2013531029A5 (https=) | ||
| EA201591000A1 (ru) | Пирролобензодиазепины | |
| NZ596615A (en) | Substituted isoquinoline derivative | |
| NO20080738L (no) | Fremgangsmater for neurobeskyttelse | |
| AR039698A1 (es) | Agonistas de los receptores cannabinoides | |
| DK0409406T3 (da) | Arylsubstituerede aminderivater, der er anvendelige ved cancerterapi | |
| PH12014500775A1 (en) | Ethynyl derivatives as mglur5 allosteric modulators | |
| JP2010527915A5 (https=) | ||
| TW200621759A (en) | Novel aminopyridine derivatives having aurora A selective inhibitory action | |
| EA200970793A1 (ru) | Модуляторы рецепторов, активируемых пролифераторами пероксисом | |
| DK1701942T3 (da) | Inhibitorer for ikke-nukleotid revers transkriptase | |
| MX2012006789A (es) | Derivados de etinilo. | |
| EA201101298A1 (ru) | Аддитивные соли трометамина с производными азабифениламинобензойной кислоты в качестве ингибиторов dhodh | |
| WO2009007536A3 (fr) | Dérivés de 7 -alkynyl-1,8-naphthyridones, leur préparation et leur application en thérapeutique | |
| PH12013501928A1 (en) | Pyrazolidin-3-one derivatives | |
| WO2008078445A1 (ja) | 重合性化合物及び重合性組成物 | |
| IN2014DN02947A (https=) | ||
| GB2470170A (en) | Dithienothiophene derivatives | |
| SG146681A1 (en) | 4-anilino-3-quinolinecarbonitriles for the treatment of chronic myelogenous leukemia (cml) | |
| JP2012006843A5 (https=) | ||
| MX2010008448A (es) | Compuesto de bencilpiperizina. | |
| CO5170535A1 (es) | Derivados de n-[2-(4-aminofenil)etil]2,3-dihidro-1,4- benzodioxin-2-metanamina, su preparacion y su aplciacion en terapeutica | |
| MX2010001512A (es) | Nuevo procedimiento de preparacion. | |
| BRPI0607407A2 (pt) | derivados de mentano carboxamida tendo propriedades de refrescáncia |